Lentigen Spurring Innovation in AIDS Vaccine Development
WASHINGTON, D.C. – As Tim Ravenscroft reflected on the lessons he’s learned during decades in the pharmaceutical, biotech and HIV/AIDS fields at a recent Congressional Biomedical Research Caucus briefing on Capitol Hill, two of his statements reverberated in my mind:
First, there is “no doubt” an AIDS vaccine remains the best hope for curbing and eventually ending the HIV/AIDS pandemic.
